Amgen Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500, Dow futures dip as big banks' earnings roll in ahead of CPI data; IBM slides
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- SK Hynix’s record plunge drags down global chip stocks
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- IBM misses Q2 targets as mainframe and software sales disappoint
- Goldman Sachs Upgrades NIO (NIO) to Buy
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- YPF Energía Eléctrica S.A. files for proposed NYSE IPO
Amgen (AMGN) Tops Q3 EPS by 57c, Reves Beat; Raises Outlook
October 28, 2020 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q3 EPS of $4.37, $0.57 better than the analyst estimate of $3.80. Revenue for the quarter came in at $6.4 billion versus the consensus estimate of $6.35 billion.
GUIDANCE:
Amgen sees FY2020 EPS of $15.80-$16.15, versus the consensus of $15.77. Amgen sees... More
